News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions -
COMMUNIQUÉ RÉGLEMENTÉ
Disclosure of transactions in own shares on June 10 to June 14, 2024
-
COMMUNIQUÉ RÉGLEMENTÉ
Déclaration hebdomadaire d'opérations effectuées du 10 au 14 juin 2024
-
COMMUNIQUÉ DE PRESSE
Launch of a capital increase open to institutional and retail investors for a total of approximately EUR12 million, with the support of HuvePharma, Fermentalg's industrial partner
Fermentalg announces a €12 million capital increase with support from HuvePharma to lead in microalgae fermentation solutions. Sales targets raised amidst strong growth momentum. Funds to achieve financial equilibrium by 2026